Warfarin: all 179 studies that test it

Page 1 of 2. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or ObesityRecruitingNCT07785934Phase 1
• Vitamin K for Perioperative Warfarin ManagementRecruitingNCT07515664Phase 4
• Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and DigoxinNot yet recruitingNCT07502001Phase 1
• A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and WarfarinRecruitingNCT07331389Phase 1
• Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 InjectionRecruitingNCT07128888Phase 1
• Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD PatientsNot yet recruitingNCT07081035Phase 4
• Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail ApproachRecruitingNCT06693960Early Phase 1
• Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary EndarterectomyRecruitingNCT05782270Phase 4
• The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on DialysisRecruitingNCT03862859Phase 4
• Low INR to Minimize Bleeding With Mechanical Valves TrialRecruitingNCT03636295Phase 3
• Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With AnticoagulationRecruitingNCT02318342Not applicable
• Use of Warfarin After the First Trimester in Pregnant Women With APSRecruitingNCT02303171Phase 4
• Determinants of Warfarin MetabolismRecruitingNCT00162474Not applicable
• A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver CirrhosisCompletedNCT05741385Not applicableResults posted
• A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the BloodCompletedNCT04679948Phase 1Results posted
• Efficacy and Safety of Anticoagulant Therapy in Portal Vein ThrombosisCompletedNCT04173429Phase 4Results posted
• Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial FibrillationTerminatedNCT03839355Phase 3Results posted
• Comparison of Oral Anticoagulants for Extended VEnous ThromboembolismTerminatedNCT03196349Phase 4Results posted
• Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial FibrillationCompletedNCT02942407Phase 4Results posted
• Apixaban Versus Warfarin for the Management of Post-operative Atrial FibrillationCompletedNCT02889562Phase 2/3Results posted
• Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and DigoxinCompletedNCT02783040Phase 1Results posted
• A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)CompletedNCT02780622Phase 4Results posted
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNCT02744092Not applicableResults posted
• Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.TerminatedNCT02696226Not applicableResults posted
• A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the BodyCompletedNCT02688088Phase 1Results posted
• XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed ThrombolysisTerminatedNCT02506985Phase 4Results posted
• A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)CompletedNCT02452918Phase 4Results posted
• Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation ServiceCompletedNCT02392104Not applicableResults posted
• Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary CalciumCompletedNCT02376010Phase 4Results posted
• The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of WarfarinCompletedNCT02287415Phase 1Results posted
• Genetic Response to Warfarin in Healthy SubjectsCompletedNCT01520402Not applicableResults posted
• Switching Study From Warfarin to RivaroxabanCompletedNCT01507051Phase 1Results posted
• A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy ParticipantsCompletedNCT01432938Phase 1Results posted
• A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of WarfarinCompletedNCT01388335Phase 1Results posted
• A Study of LY2216684 and Warfarin in Healthy SubjectsCompletedNCT01263119Phase 1Results posted
• Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft OcclusionTerminatedNCT01246011Phase 4Results posted
• Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult VolunteersCompletedNCT01178853Phase 4Results posted
• Drug Drug Interaction of Empagliflozin (BI 10773) and Warfarin in Healthy VolunteersCompletedNCT01111331Phase 1Results posted
• Anticoagulation For Pulmonary Hypertension in Sickle Cell DiseaseTerminatedNCT01036802Phase 2Results posted
• A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic MelanomaCompletedNCT01001299Phase 1Results posted
• Clinical and Economic Implications of Genetic Testing for Warfarin ManagementCompletedNCT00964353Phase 4Results posted
• AntiCoagulant Effectiveness in Idiopathic Pulmonary FibrosisTerminatedNCT00957242Phase 3Results posted
• Prothrombin Times Outside the Therapeutic Range in Otherwise Stable PatientsCompletedNCT00814177Phase 2Results posted
• Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.CompletedNCT00777855Not applicableResults posted
• D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous ThromboembolismTerminatedNCT00428441Not applicableResults posted
• Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic InformationCompletedNCT00401414Not applicableResults posted
• Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran EtexilateCompletedNCT00262600Phase 3Results posted
• Treatment of Upper Extremity Deep-Vein ThrombosisCompletedNCT00245856Phase 4Results posted
• Odiparcil For The Prevention Of Venous ThromboembolismCompletedNCT00244725Phase 2Results posted
• Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus InfectionCompletedNCT00180674Phase 2Results posted
• Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) TrialCompletedNCT00041938Phase 3Results posted
• Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein ThrombosisCompletedNCT07571460Phase 4
• Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous ThrombosisCompletedNCT07523347Not applicable
• Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and DigoxinActive, not recruitingNCT07362030Phase 1
• COMPARISON OF WARFARIN AND RIVAROXABAN IN THE TREATMENT OF LOWER LIMB DEEP VENOUS THROMBOSISCompletedNCT07077954Phase 1
• A Study of BGM0504 in Overweight or Obese ParticipantsCompletedNCT06920056Phase 1
• A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)CompletedNCT06772779Phase 1
• Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy SubjectsCompletedNCT06723691Phase 1
• The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)Active, not recruitingNCT06449469Not applicable
• A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or DigoxinCompletedNCT06335134Phase 1
• A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body WeightCompletedNCT06289504Phase 1
• A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese SubjectsCompletedNCT05815680Phase 1
• A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Midazolam and Warfarin in Healthy Male SubjectsCompletedNCT05480488Phase 1
• Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft SurgeryStatus unknownNCT05300555Phase 4
• A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy VolunteersCompletedNCT05273775Phase 1
• A Study to Evaluate the Drug-drug Interactions (DDIs) of DBPR108 With Warfarin Sodium, Digoxin, Probenecid in Healthy SubjectsCompletedNCT05045313Phase 1
• Effect of BIA 5-1058 400 mg on Warfarin PharmacokineticsCompletedNCT04994119Phase 1
• Pemvidutide (ALT-801) DDI Study in Healthy VolunteersCompletedNCT04972396Phase 1
• Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)CompletedNCT04730037Phase 3
• A Drug Interaction Study of DanicopanCompletedNCT04709094Phase 1
• The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and OmeprazoleCompletedNCT04676035Phase 1
• Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）CompletedNCT04645550Phase 4
• Warfarin Initiation in Mechanical Mitral Valve Replacement PatientsCompletedNCT04235569Phase 4
• DOAC Versus VKA After Cardiac SurgeryWithdrawnNCT04002011Phase 2
• Strategies for the Management of Atrial Fibrillation in patiEnts Receiving DialysisCompletedNCT03987711Phase 2
• Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapyStatus unknownNCT03885180Not applicable
• Anticoagulation for Aortic Bioprosthesis (ANTIPRO)CompletedNCT03807921Phase 4
• Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS)Status unknownNCT03781258Not applicable
• Anti-thrombotic Monotherapy With the HeartMate 3 LVASStatus unknownNCT03704220Not applicable
• Biological Effect of Warfarin on Pancreatic CancerWithdrawnNCT03536208Early Phase 1
• Acute Mesenteric Venous Thrombosis.. in Assiut University Hospital Management ControversiesStatus unknownNCT03483207Not applicable
• A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult SubjectsCompletedNCT03363815Phase 1
• Apixaban Versus Warfarin in Patients With Left Ventricular (LV) ThrombusCompletedNCT03232398Phase 3
• Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous ThrombosisStatus unknownNCT03191305Not applicable
• The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary ThromboembolismStatus unknownNCT03185845Not applicable
• Dabigatran in Patients With Atrial Fibrillation and Mitral Biological ProsthesesStatus unknownNCT03183843Phase 4
• Start or STop Anticoagulants Randomised Trial (SoSTART)CompletedNCT03153150Phase 3
• MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)Status unknownNCT03078374Not applicable
• ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)CompletedNCT02935855Phase 4
• Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee ReplacementCompletedNCT02810704Phase 4
• This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic ArthritisCompletedNCT02772601Phase 1
• Pharmacokinetic Drug-Drug Interaction Study of RucaparibCompletedNCT02740712Phase 1
• Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult VolunteersCompletedNCT02719431Phase 1
• Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.Status unknownNCT02704598Not applicable
• The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCTStatus unknownNCT02630095Phase 4
• A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy ParticipantsCompletedNCT02617810Phase 1
• Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in PatientsStatus unknownNCT02592980Phase 4
• Assessment of 2012 Bioequivalence Standards for WarfarinCompletedNCT02574754Phase 1
• Drug Interaction Study of Warfarin and MT-3995CompletedNCT02531568Phase 1
• Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver CirrhosisWithdrawnNCT02526303Not applicable

← Warfarin overview